<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRA</journal-id>
<journal-id journal-id-type="hwp">spjra</journal-id>
<journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id>
<journal-title>Journal of the Renin-Angiotensin-Aldosterone System</journal-title>
<issn pub-type="ppub">1470-3203</issn>
<issn pub-type="epub">1752-8976</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1470320312438792</article-id>
<article-id pub-id-type="publisher-id">10.1177_1470320312438792</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Renin and prorenin have no direct effect on aldosterone synthesis in the human adrenocortical cell lines H295R and HAC15</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Jansen</surname><given-names>Pieter M</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312438792">1</xref>
<xref ref-type="fn" rid="fn1-1470320312438792">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hofland</surname><given-names>Johannes</given-names></name>
<xref ref-type="aff" rid="aff2-1470320312438792">2</xref>
<xref ref-type="fn" rid="fn1-1470320312438792">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>van den Meiracker</surname><given-names>Anton H</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312438792">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>de Jong</surname><given-names>Frank H</given-names></name>
<xref ref-type="aff" rid="aff2-1470320312438792">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Danser</surname><given-names>AH Jan</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312438792">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1470320312438792"><label>1</label>Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus Medical Centre Rotterdam, The Netherlands</aff>
<aff id="aff2-1470320312438792"><label>2</label>Division of Endocrinology, Department of Internal Medicine, Erasmus Medical Centre Rotterdam, The Netherlands</aff>
<author-notes>
<corresp id="corresp1-1470320312438792">AHJ Danser, Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, room EE1418b, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. Email: <email>a.danser@erasmusmc.nl</email></corresp>
<fn fn-type="other" id="fn1-1470320312438792">
<label>*</label>
<p>These authors contributed equally</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<fpage>360</fpage>
<lpage>366</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1470320312438792">
<title>Introduction:</title>
<p>Transgenic rats expressing the human (pro)renin receptor (h(P)RR) have elevated plasma aldosterone levels despite unaltered levels, in plasma and adrenal, of renin and angiotensin II.</p>
</sec>
<sec id="section2-1470320312438792">
<title>Materials and methods:</title>
<p>To investigate whether renin/prorenin–(P)RR interaction underlies these elevated aldosterone levels, the effect of (pro)renin on steroidogenesis was compared with that of angiotensin II in two (P)RR-expressing human adrenocortical cell lines, H295R and HAC15. Angiotensin II rapidly induced extracellular signal-regulated kinase (ERK) phosphorylation and increased the expression of STAR, CYP21A2, CYP11B2, and CYP17A1 at 6 and 24 hours, whereas the expression of CYP11A1 and HSD3B2 remained unaltered. Incubation with renin or prorenin at nanomolar concentrations had no effect on the expression of any of the steroidogenic enzymes tested, nor resulted in ERK phosphorylation. Angiotensin II, but not renin or prorenin, induced aldosterone production.</p>
</sec>
<sec id="section3-1470320312438792">
<title>Conclusion:</title>
<p>Although the (P)RR is present in adrenocortical cells, renin and prorenin do not elicit ERK phosphorylation nor directly affect steroid production via this receptor at nanomolar concentrations. Thus, direct (pro)renin–(P)RR interaction is unlikely to contribute to the elevated aldosterone levels in human (P)RR transgenic rats. This conclusion also implies that the aldosterone rise that often occurs during prolonged renin–angiotensin system blockade is rather due to the angiotensin II ‘escape’ during such blockade.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Renin</kwd>
<kwd>prorenin</kwd>
<kwd>(pro)renin receptor</kwd>
<kwd>angiotensin</kwd>
<kwd>aldosterone</kwd>
<kwd>adrenal gland</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section4-1470320312438792" sec-type="intro">
<title>Introduction</title>
<p>(Pro)renin receptors ((P)RRs) bind both renin and its inactive precursor, prorenin, and such binding allows prorenin to display angiotensin (Ang) I-generating activity.<sup><xref ref-type="bibr" rid="bibr1-1470320312438792">1</xref><xref ref-type="bibr" rid="bibr2-1470320312438792"/><xref ref-type="bibr" rid="bibr3-1470320312438792"/>–<xref ref-type="bibr" rid="bibr4-1470320312438792">4</xref></sup> Surprisingly, renin and prorenin also act as agonists for this receptor, inducing effects in an angiotensin-independent manner.<sup><xref ref-type="bibr" rid="bibr1-1470320312438792">1</xref>, <xref ref-type="bibr" rid="bibr5-1470320312438792">5</xref><xref ref-type="bibr" rid="bibr6-1470320312438792"/>–<xref ref-type="bibr" rid="bibr7-1470320312438792">7</xref></sup> Transgenic rats with either ubiquitous or vascular smooth muscle-specific expression of the human (P)RR have increased plasma aldosterone levels. Yet, their plasma levels of renin and angiotensin are normal,<sup><xref ref-type="bibr" rid="bibr8-1470320312438792">8</xref>,<xref ref-type="bibr" rid="bibr9-1470320312438792">9</xref></sup> and elevated adrenal levels of Ang II did not occur in the animals with ubiquitous (P)RR expression.<sup><xref ref-type="bibr" rid="bibr10-1470320312438792">10</xref></sup> Possibly therefore, renin- and/or prorenin-induced stimulation of this receptor in the adrenal cortex (i.e. independently of angiotensin) is responsible for increased aldosterone production. Recently, the (P)RR was shown to be present in aldosterone-producing adenomas (APAs) as well as in two adrenocortical cell lines (H295R and HAC15) suggesting a role for this receptor in aldosterone synthesis.<sup><xref ref-type="bibr" rid="bibr11-1470320312438792">11</xref></sup> Indeed, adrenal (P)RR expression in (P)RR transgenic rats correlated with CYP11B2 expression.<sup><xref ref-type="bibr" rid="bibr10-1470320312438792">10</xref></sup> Moreover, some of the mitogen-activated protein (MAP) kinases linked to aldosterone synthesis and release (extracellular signal regulated 1/2 [ERK1/2] and p38 mitogen-activated protein kinase [MAPK]),<sup><xref ref-type="bibr" rid="bibr12-1470320312438792">12</xref>,<xref ref-type="bibr" rid="bibr13-1470320312438792">13</xref></sup> are known to be activated by renin/prorenin (hereafter referred to as (pro)renin) binding to the (P)RR.<sup><xref ref-type="bibr" rid="bibr7-1470320312438792">7</xref>,<xref ref-type="bibr" rid="bibr14-1470320312438792">14</xref></sup></p>
<p>Aldosterone is produced from cholesterol through a series of enzymatic reactions involving cytochrome P450 (CYP) enzymes and a hydroxysteroid dehydrogenase (HSD). After mitochondrial transport by steroid acute regulatory protein (encoded by STAR), cholesterol is converted into pregnenolone by P450scc (CYP11A1). Aldosterone is formed through sequential reactions by 3β-HSD (HSD3B2), 21-hydroxylase (CYP21A2) and aldosterone synthase (CYP11B2). P450c17 (CYP17A1) diverts steroidogenesis from aldosterone towards glucocorticoid and sex steroid synthesis.<sup><xref ref-type="bibr" rid="bibr15-1470320312438792">15</xref></sup> These enzymes are present in the adrenocortical carcinoma cell lines H295R and HAC15, making them useful and well-characterized models to study regulatory mechanisms for aldosterone synthesis.<sup><xref ref-type="bibr" rid="bibr16-1470320312438792">16</xref><xref ref-type="bibr" rid="bibr17-1470320312438792"/>–<xref ref-type="bibr" rid="bibr18-1470320312438792">18</xref></sup></p>
<p>The purpose of this study was to assess whether there is a direct, Ang II-independent effect, of prorenin and/or renin on the MAP kinase signalling cascade and adrenocortical steroidogenesis in H295R and HAC15 cells. To that end, we studied the effects of (pro)renin on aldosterone production and steroidogenic enzyme expression in these cells.</p>
</sec>
<sec id="section5-1470320312438792" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section6-1470320312438792">
<title>Cell culture studies</title>
<p>H295R cells (<italic>ATCC, Manassas, VA</italic>) were maintained in DMEM/F12, containing 5% foetal calf serum (FCS), 400 IU/ml penicillin and 0.4 mg/ml streptomycin (Invitrogen, Carlsbad, CA). H295R cells were seeded in 24-well plates at a concentration of 1 x 10<sup>5</sup> cells/ml for 24 hours. Cells were then serum-starved overnight and subsequently incubated with Ang II (Sigma-Aldrich, St. Louis, MO; 100 nmol/l), recombinant human renin (see below, 1 and 10 nmol/l), or recombinant human prorenin (1 nmol/l). Renin was applied at higher concentrations than prorenin, given its lower affinity for the (P)RR (2). At 6, 24 and 48 hours medium was removed and the plates were snap-frozen and stored at −80°C until further analysis.</p>
<p>HAC15 cells (kindly provided by Dr WE Rainey, Medical College of Georgia, Augusta, GA) were maintained in DMEM/F12 containing 10% cosmic calf serum (CCS, Thermo Scientific, Breda, The Netherlands), penicillin and streptomycin. These cells were seeded in 24-well plates at a concentration of 1 x 10<sup>5</sup> cells/ml for 24 hours. Cells were put on 0.1% CCS overnight and subsequently incubated with Ang II (100 nmol/l<sup><xref ref-type="bibr" rid="bibr19-1470320312438792">19</xref><xref ref-type="bibr" rid="bibr20-1470320312438792"/>–<xref ref-type="bibr" rid="bibr21-1470320312438792">21</xref></sup>), recombinant human renin (10 nmol/l), recombinant human prorenin (2.5 nmol/l), or Ang II in combination with renin or prorenin. At 48 hours culture media were collected and the plates were snap-frozen and stored at −80<sup>°</sup>C until further analysis.</p>
<p>To study whether renin or prorenin activates the ERK1/2 phosphorylation pathway H295R cells were seeded in six-well plates at a concentration of 4.5 x 10<sup>5</sup> cells/ml for 24 hours. Cells were serum-starved overnight and subsequently stimulated with Ang II (100 nmol/l), recombinant human renin (10 nmol/l), or recombinant human prorenin (2.5 nmol/l). After 5 and 30 minutes of incubation the cells were harvested and lysed with lysis buffer containing protease inhibitor Complete (Roche, Almere, The Netherlands) and phosphatase inhibitor mixture (Sigma, Zwijndrecht, The Netherlands) as described previously.<sup><xref ref-type="bibr" rid="bibr7-1470320312438792">7</xref></sup> The cell lysates were stored at −20<sup>°</sup>C until Western blot analysis.</p>
<p>The capacity of H295R cells to generate (pro)renin was assessed by collecting medium following exposure of the cells to 10 μmol/l forskolin (Sigma-Aldrich) or 1 mmol/l cAMP (Sigma-Aldrich) (to maximally stimulate renin release<sup><xref ref-type="bibr" rid="bibr22-1470320312438792">22</xref></sup>) for 48 hours in the absence or presence of 5% FCS. In order to evaluate their angiotensin-converting enzyme (ACE) content, serum-starved cells were incubated at 37°C with 10 nmol/l Ang I in the absence or presence of 10 μmol/l captopril. Medium samples (50 μl) for Ang I and II measurements were then collected at 30, 60, 180 and 360 minutes and rapidly mixed with angiotensinase inhibitor mix as described previously.<sup><xref ref-type="bibr" rid="bibr23-1470320312438792">23</xref></sup></p>
</sec>
<sec id="section7-1470320312438792">
<title>Recombinant human (pro)renin</title>
<p>Recombinant human prorenin was a kind gift from Dr S Matthews (Hoffmann-LaRoche, Basel, Switzerland). It was secreted by CHO cells transfected with a vector containing human prorenin cDNA. It was partially purified, to remove traces of renin, by Cibacron Blue Sepharose affinity chromatography (Amersham Pharmacia Biotech, Roosendaal, The Netherlands). The intrinsic renin activity of the prorenin preparation, prior to proteolytic activation, was less than 2% of the activity after complete proteolytic activation.<sup><xref ref-type="bibr" rid="bibr24-1470320312438792">24</xref></sup> After proteolytic activation the prorenin preparation contained approximately 4 µmol/l renin.</p>
</sec>
<sec id="section8-1470320312438792">
<title>(P)RR expression</title>
<p>(P)RR expression was investigated in non-stimulated H295R cells and human adrenal tissue, obtained as residual tissue after nephrectomy (<italic>n</italic> = 2), by reverse transcriptase-polymerase chain reaction (RT-PCR). Cells and frozen tissues were homogenized in TRIzol reagent (Invitrogen) with the Polytron PT 3000 (Kinematica AG, Littau-Luzern, Switzerland) and RNA was isolated according to the manufacturer’s instructions. Following isolation, 1 μg of RNA was reverse transcribed as described previously.<sup><xref ref-type="bibr" rid="bibr25-1470320312438792">25</xref></sup> In the PCR reaction, CAT TGT CCA TGG GCT TCT CT was used as forward primer, and two different reverse primers (CAA ACT TTT GCA GAG CGT CA and ATC CAG GAT CCA TGT TCC AA) were used, resulting, respectively, in the detection of 603 and 864 bp fragments.<sup><xref ref-type="bibr" rid="bibr1-1470320312438792">1</xref></sup> A 30 μl mixture containing AmpliTAQ mix (Roche Applied Science, Penzberg, Germany), dNTPs, 1250 nmol/l primers and 30 ng cDNA was incubated for 5 minutes at 95°C. Amplification was performed in forty cycles consisting of the following steps: 1 minute at 95°C, 1 minute at 64°C, and 1 minute at 72°C. The amplification was ended with a 10-minute incubation at 72°C. PCR products were run on an agarose 2% gel.</p>
</sec>
<sec id="section9-1470320312438792">
<title>Western blotting</title>
<p>For the detection of ERK1/2 and phosphorylated ERK1/2, 10 μg of protein was loaded on a 12% polyacrylamide gel. For the detection of (P)RR and β-actin, 20 μg of protein was applied. Cell lysates of Mardin Darby Canine Kidney (MDCK) cells (15 μg protein) were used as a positive control for the presence of the (P)RR. We used polyclonal rabbit antibodies against ERK1/2 and phospho-ERK1/2 (Cell Signaling, Danvers, MA) for the detection of total and phosphorylated ERK, polyclonal rabbit anti-ATP6AP2 antibodies (Sigma-Aldrich) for the detection of the (P)RR, and monoclonal mouse anti-actin (clone C4) antibodies (Millipore, Amsterdam, The Netherlands) for the detection of β-actin. Horseradish peroxidase-conjugated secondary antibodies were purchased from Biorad (Veenendaal, The Netherlands). Blots were developed with chemiluminescence substrate. Quantification of protein levels was performed with Image J (National Institutes of Health, Bethesda, MD).</p>
</sec>
<sec id="section10-1470320312438792">
<title>RNA isolation and quantitative RT-PCR</title>
<p>RNA was isolated from the H295R cells using TRIzol, followed by reverse transcription. Thereafter, expression of steroidogenic enzyme and housekeeping gene hypoxanthine ribosyl transferase 1 (HPRT1) mRNAs was evaluated using real-time PCR as described previously.<sup><xref ref-type="bibr" rid="bibr25-1470320312438792">25</xref></sup> Primer and probe sequences have been described previously.<sup><xref ref-type="bibr" rid="bibr15-1470320312438792">15</xref></sup> cDNA specificity was checked for each gene product and PCR efficiency exceeded 90% for each probe–primer pair. Expression of mRNAs was calculated relative to HPRT1 using the δCt-method.</p>
</sec>
<sec id="section11-1470320312438792">
<title>Prorenin, renin, angiotensin and aldosterone measurements</title>
<p>Renin and prorenin in the culture medium were measured by immunoradiometric assay (Cisbio Bioassays, Bagnols-sur-Cèze, France) as described before.<sup><xref ref-type="bibr" rid="bibr26-1470320312438792">26</xref></sup> The detection limit was 0.024 pmol/l. Ang I and II were measured with sensitive radioimmunoassay.<sup><xref ref-type="bibr" rid="bibr27-1470320312438792">27</xref></sup> Their detection limits were 80 and 40 pmol/l, respectively. Aldosterone was measured with a radioimmunoassay (Coat-a Count, Siemens-DPC, Los Angeles, CA) with a detection limit of 61 pmol/l.</p>
</sec>
<sec id="section12-1470320312438792">
<title>Statistical analysis</title>
<p>Levels are expressed as mean ± standard error of the mean (SEM). ERK phosphorylation and log-converted steroidogenic enzyme expression levels were analysed by one-way analysis of variance (ANOVA), applying post-hoc Dunnett’s test for multiple comparisons. Aldosterone levels were analysed by Kruskal–Wallis test, applying post-hoc Dunn’s test for multiple comparisons because of a non-Gaussian distribution even after log-conversion. <italic>p</italic>-values &lt;0.05 were considered statistically significant. Analyses were performed with GraphPad Prism 5.01 (GraphPad Software Inc., San Diego, CA).</p>
</sec>
</sec>
<sec id="section13-1470320312438792" sec-type="results">
<title>Results</title>
<sec id="section14-1470320312438792">
<title>Local expression of the (P)RR and RAAS components</title>
<p>Both H295R cells and human adrenal tissue expressed the (P)RR, as evidenced by the appearance of the expected 603 and 864 bp fragments following RT-PCR (data not shown). Western blots on H295R cell lysates confirmed the presence of the (P)RR protein (<xref ref-type="fig" rid="fig1-1470320312438792">Figure 1</xref>).</p>
<fig id="fig1-1470320312438792" position="float">
<label>Figure 1.</label>
<caption><p>Western blot analysis on the presence of the (pro)renin receptor ((P)RR) in the H295R cell line with β-actin serving as reference for protein loading. Mardin Darby Canine Kidney (MDCK) cells were used as positive control for (P)RR expression; they yielded a product of similar size.</p></caption>
<graphic xlink:href="10.1177_1470320312438792-fig1.tif"/>
</fig>
<p>Neither renin nor prorenin could be detected in the medium of forskolin- or cAMP-stimulated H295R cells with or without serum (<italic>n</italic> = 3). The cells metabolized Ang I to the same degree without or with captopril ((<italic>t</italic><sub>1/2</sub> 2.1 ± 0.1 and 2.6 ± 0.2 hours, respectively; <italic>n</italic> = 4), and Ang II in the medium remained below the limit of detection under all conditions.</p>
</sec>
<sec id="section15-1470320312438792">
<title>Effect of (pro)renin on adrenocortical cells</title>
<p>Incubation with Ang II rapidly induced phosphorylation of ERK at both 5 and 30 minutes, whereas supraphysiological concentrations of both renin and prorenin did not (<xref ref-type="fig" rid="fig2-1470320312438792">Figure 2</xref>).</p>
<fig id="fig2-1470320312438792" position="float">
<label>Figure 2.</label>
<caption><p>Total ERK1/2 (ERK) and phosphorylated ERK1/2 (p-ERK) in H295R cells after a 5-minute incubation with angiotensin II (Ang II, 100 nmol/l), renin (10 nmol/l), and prorenin (2.5 nmol/l) analysed by Western blot (A). Quantification of ERK phosphorylation relative to unstimulated cells at 5 and 30 minutes stimulation (B). *** <italic>p</italic> &lt; 0.001 versus control. Values are mean ± SEM of six experiments except for Ang II at <italic>t</italic> = 5 min and control at <italic>t</italic> = 30 min (<italic>n</italic> = 5).</p></caption>
<graphic xlink:href="10.1177_1470320312438792-fig2.tif"/>
</fig>
<p>Aldosterone concentrations in the supernatants of unstimulated H295R cells were below the detection limit of the assay. Ang II led to a rise in aldosterone concentration in HAC15 cell culture media after 48 hours of incubation (<xref ref-type="fig" rid="fig3-1470320312438792">Figure 3</xref>). This was not affected by coincubation with renin or prorenin. Stimulation with renin or prorenin alone did not result in higher aldosterone secretion as compared with unstimulated cells.</p>
<fig id="fig3-1470320312438792" position="float">
<label>Figure 3.</label>
<caption><p>Aldosterone concentrations in HAC15 culture media after 48 hours of incubation with renin (10 nmol/l), prorenin (2.5 nmol/l), angiotensin II (Ang II, 100 nmol/l), and Ang II (100 nmol/l) coincubated with renin (10 nmol/l) or prorenin (2.5 nmol/l), compared with unstimulated cells. ***<italic>p</italic> &lt; 0.001 versus control. Values are mean ± SEM of 12 experiments.</p></caption>
<graphic xlink:href="10.1177_1470320312438792-fig3.tif"/>
</fig>
<p>Ang II (<italic>n</italic> = 4) significantly increased the expression of STAR, CYP11B2, CYP21A2 and CYP171A1 (<xref ref-type="fig" rid="fig4-1470320312438792">Figure 4</xref>) in H295R cells at 6 and/or 24 hours, but not at 48 hours. No significant effects were observed for HSD3B2 and CYP11A1 (data not shown). Renin and prorenin (<italic>n</italic> = 4 for all concentrations) had no significant effect on the expression of any of the steroidogenic enzymes studied. After 48 hours of incubation only Ang II (in the presence or absence of (pro)renin), but not renin or prorenin alone, increased the expression of CYP11B2, and decreased the expression of CYP17A1 in HAC15 cells (<italic>n</italic> = 3 for all conditions; <xref ref-type="fig" rid="fig5-1470320312438792">Figure 5</xref>). No significant effects were observed for the expression of the other steroidogenic enzymes.</p>
<fig id="fig4-1470320312438792" position="float">
<label>Figure 4.</label>
<caption><p>Expression of STAR, CYP21A2, CYP11B2 and CYP17A1 mRNA in H295R cells after incubation with angiotensin II (Ang II, 100 nmol/l), renin (1 and 10 nmol/l) and prorenin (1 nmol/l) for 6, 24 and 48 hours. Values were related to the housekeeping gene HPRT1 and depicted relative to unstimulated cells (mean ± SEM of four experiments). *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 versus control.</p></caption>
<graphic xlink:href="10.1177_1470320312438792-fig4.tif"/>
</fig>
<fig id="fig5-1470320312438792" position="float">
<label>Figure 5.</label>
<caption><p>Expression of STAR, CYP21A2, CYP11B2 and CYP17A1 mRNA in HAC15 cells after incubation with angiotensin II (Ang II, 100 nmol/l), renin (10 nmol/l), prorenin (2.5 nmol/l) for 48 hours. Values were related to the housekeeping gene HPRT1 and depicted relative to unstimulated cells (mean ± SEM of three experiments). *<italic>p</italic> &lt; 0.05 versus control.</p></caption>
<graphic xlink:href="10.1177_1470320312438792-fig5.tif"/>
</fig>
</sec>
</sec>
<sec id="section16-1470320312438792" sec-type="discussion">
<title>Discussion</title>
<p>Transgenic rats overexpressing the human (P)RR have increased levels of plasma aldosterone despite normal plasma and tissue levels of renin and Ang II.<sup><xref ref-type="bibr" rid="bibr8-1470320312438792">8</xref><xref ref-type="bibr" rid="bibr9-1470320312438792"/>–<xref ref-type="bibr" rid="bibr10-1470320312438792">10</xref></sup> Given the direct effects of both renin and prorenin via (P)RR-mediated activation of ERK1/2 and p38 MAPK,<sup><xref ref-type="bibr" rid="bibr1-1470320312438792">1</xref>,<xref ref-type="bibr" rid="bibr14-1470320312438792">14</xref></sup> we hypothesized that renin and prorenin might directly stimulate aldosterone synthesis through activation of the adrenocortical (P)RR. This hypothesis was tested in the adrenocortical cell lines H295R and HAC15, making use of nanomolar levels of (pro)renin. These concentrations were chosen based on previous in-vitro studies showing effects of (pro)renin in cardiomyocytes, monocytes and renal cells.<sup><xref ref-type="bibr" rid="bibr5-1470320312438792">5</xref>,<xref ref-type="bibr" rid="bibr7-1470320312438792">7</xref>,<xref ref-type="bibr" rid="bibr14-1470320312438792">14</xref>,<xref ref-type="bibr" rid="bibr28-1470320312438792">28</xref></sup> It should be realized that such concentrations are three or four orders of magnitude above the physiological levels of (pro)renin.<sup><xref ref-type="bibr" rid="bibr29-1470320312438792">29</xref></sup> Although (pro)renin levels may rise under pathological conditions and/or during renin–angiotensin system (RAS) blockade, such rises are usually &lt;10-fold,<sup><xref ref-type="bibr" rid="bibr29-1470320312438792">29</xref><xref ref-type="bibr" rid="bibr30-1470320312438792"/>–<xref ref-type="bibr" rid="bibr31-1470320312438792">31</xref></sup> i.e. far below the 1000–10,000-fold higher levels applied here. Therefore, at most, such high levels might exist at sites where (pro)renin is produced, e.g. in the kidney and the adrenal gland.</p>
<p>First, (P)RR expression in H295R cells was confirmed both at the mRNA and protein level. Second, we verified whether H295R cells are capable of generating RAS components. In agreement with a previous study,<sup><xref ref-type="bibr" rid="bibr32-1470320312438792">32</xref></sup> we were unable to detect ACE activity in these cells. In fact, following the addition of Ang I to the medium, these cells did not generate any Ang II, ruling out Ang II generation by non-ACE pathways as well.</p>
<p>Adrenal cells are thought to express a renin transcript lacking exon 1, encoding for a non-secretory intracellular renin.<sup><xref ref-type="bibr" rid="bibr33-1470320312438792">33</xref></sup> Immunohistochemistry indeed supported the cytosolic presence of renin in H295R cells.<sup><xref ref-type="bibr" rid="bibr32-1470320312438792">32</xref></sup> We were unable to detect renin or prorenin in the medium of these cells, even following stimulation of the renin-stimulatory<sup><xref ref-type="bibr" rid="bibr22-1470320312438792">22</xref></sup> adenylyl cyclase-cAMP pathway. This confirms that renin lacking the transport signal (which is encoded by a signal derived from exon 1 of the renin gene) cannot be secreted.<sup><xref ref-type="bibr" rid="bibr34-1470320312438792">34</xref></sup> The function of intracellular renin is so far unknown. Although elevated levels of adrenal (cytosolic) renin have been reported to occur in conjunction with elevated plasma levels of aldosterone,<sup><xref ref-type="bibr" rid="bibr34-1470320312438792">34</xref></sup> it remains to be determined whether intracellular renin displays Ang I-generating activity, and if so, to what degree it has access to angiotensinogen in adrenal cells. Alternatively, such renin might stimulate intracellular (P)RRs in an Ang II-independent manner, and thereby increase aldosterone synthesis. Renin and prorenin, when added to the medium, will accumulate intracellularly,<sup><xref ref-type="bibr" rid="bibr2-1470320312438792">2</xref>,<xref ref-type="bibr" rid="bibr35-1470320312438792">35</xref>,<xref ref-type="bibr" rid="bibr36-1470320312438792">36</xref></sup> and thus our experimental approach should allow the stimulation of (P)RRs both on the cell surface and in the cells.</p>
<p>The current study, however, does not support aldosterone synthesis by adrenocortical cells following their exposure to nanomolar concentrations of either renin or prorenin. In fact, although present in H295R cells, stimulation of the (P)RR with renin or prorenin did not lead to phosphorylation of ERK1/2. In contrast, Ang II did induce ERK1/2 phosphorylation and resulted in a profound stimulation of steroidogenic enzyme expression, in particular aldosterone synthase (CYP11B2), in full agreement with previous reports.<sup><xref ref-type="bibr" rid="bibr17-1470320312438792">17</xref>,<xref ref-type="bibr" rid="bibr19-1470320312438792">19</xref></sup> Aldosterone concentrations in culture media of unstimulated H295R cells remained below the detection limit. In order to be able to assess even small effects on aldosterone secretion, additional experiments were performed in HAC15 cells. Ang II, but not renin or prorenin, increased aldosterone secretion in these cells. Clearly, therefore, our findings rule out a direct effect of renin/prorenin on aldosterone synthesis via activation of (P)RR on either the cell surface or in the cells.</p>
<p>One may speculate that, in the intact adrenal gland in vivo, in the presence of sufficient angiotensinogen and ACE, (pro)renin binding to the (P)RR would allow angiotensin generation, thus resulting in aldosterone synthesis in an indirect (Ang II-dependent) manner. However, given the unchanged plasma and tissue angiotensin levels in (P)RR transgenic rats,<sup><xref ref-type="bibr" rid="bibr8-1470320312438792">8</xref><xref ref-type="bibr" rid="bibr9-1470320312438792"/>-<xref ref-type="bibr" rid="bibr10-1470320312438792">10</xref></sup> this mechanism cannot underlie the elevated aldosterone levels in these rats.</p>
<p>In conclusion, neither renin nor prorenin stimulates aldosterone synthesis directly via (P)RR in H295R and HAC15 cells, not even when applied at supraphysiological levels. Most likely therefore, the elevated aldosterone levels in (P)RR transgenic rats are the consequence of other mechanisms. Given the recent observation that the (P)RR is indispensable for the integrity of vacuolar H<sup>+</sup>-ATPase (an enzyme that plays an important role in the acidification of subcellular compartments),<sup><xref ref-type="bibr" rid="bibr37-1470320312438792">37</xref></sup> one possibility is that intracellular pH changes per se (i.e., independently of renin/prorenin) affect aldosterone synthesis. Alternatively, the renal damage in (P)RR transgenic rats may stimulate adrenal aldosterone production via an increase in serum potassium levels.<sup><xref ref-type="bibr" rid="bibr8-1470320312438792">8</xref>,<xref ref-type="bibr" rid="bibr9-1470320312438792">9</xref></sup> Although (P)RR blockade with the handle region peptide (HRP) prevented renal damage in (P)RR transgenic rats,<sup><xref ref-type="bibr" rid="bibr38-1470320312438792">38</xref></sup> the effect of such normalization on plasma aldosterone levels or serum potassium levels has not yet been reported. Importantly, the current data rule out that the ‘aldosterone escape’ occurring during single or dual RAS blockade<sup><xref ref-type="bibr" rid="bibr39-1470320312438792">39</xref>,<xref ref-type="bibr" rid="bibr40-1470320312438792">40</xref></sup> is due to the renin/prorenin rise that accompanies such blockade. More likely, the Ang II escape that usually also occurs during prolonged RAS blockade<sup><xref ref-type="bibr" rid="bibr41-1470320312438792">41</xref>,<xref ref-type="bibr" rid="bibr42-1470320312438792">42</xref></sup> contributes to this aldosterone rise.</p>
</sec>
</body>
<back>
<ack><p>Dr WE Rainey is gratefully acknowledged for providing the HAC15 cell line.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>PMJ is financially supported by the Dutch Kidney Foundation (grant number C05.2151).</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>The authors declare no conflict of interest in preparing this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1470320312438792">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>G</given-names></name>
<name><surname>Delarue</surname><given-names>F</given-names></name>
<name><surname>Burcklé</surname><given-names>C</given-names></name>
<name><surname>Bouzhir</surname><given-names>L</given-names></name>
<name><surname>Giller</surname><given-names>T</given-names></name>
<name><surname>Sraer</surname><given-names>J-D</given-names></name>
</person-group>. <article-title>Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin</article-title>. <source>J Clin Invest</source> <year>2002</year>; <volume>109</volume>: <fpage>1417</fpage>–<lpage>1427</lpage>.</citation>
</ref>
<ref id="bibr2-1470320312438792">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Batenburg</surname><given-names>WW</given-names></name>
<name><surname>Krop</surname><given-names>M</given-names></name>
<name><surname>Garrelds</surname><given-names>IM</given-names></name>
<etal/>
</person-group>. <article-title>Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor</article-title>. <source>J Hypertens</source> <year>2007</year>; <volume>25</volume>: <fpage>2441</fpage>–<lpage>2453</lpage>.</citation>
</ref>
<ref id="bibr3-1470320312438792">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Batenburg</surname><given-names>WW</given-names></name>
<name><surname>de Bruin</surname><given-names>RJ</given-names></name>
<name><surname>van Gool</surname><given-names>JM</given-names></name>
<etal/>
</person-group>. <article-title>Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <year>2008</year>; <volume>28</volume>: <fpage>1151</fpage>–<lpage>1157</lpage>.</citation>
</ref>
<ref id="bibr4-1470320312438792">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nabi</surname><given-names>AHMN</given-names></name>
<name><surname>Kageshima</surname><given-names>A</given-names></name>
<name><surname>Uddin</surname><given-names>MN</given-names></name>
<name><surname>Nakagawa</surname><given-names>T</given-names></name>
<name><surname>Park</surname><given-names>EY</given-names></name>
<name><surname>Suzuki</surname><given-names>F</given-names></name>
</person-group>. <article-title>Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system</article-title>. <source>Int J Mol Med</source> <year>2006</year>; <volume>18</volume>: <fpage>483</fpage>–<lpage>488</lpage>.</citation>
</ref>
<ref id="bibr5-1470320312438792">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Y</given-names></name>
<name><surname>Noble</surname><given-names>NA</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Xu</surname><given-names>C</given-names></name>
<name><surname>Border</surname><given-names>WA</given-names></name>
</person-group>. <article-title>Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells</article-title>. <source>Kidney Int</source> <year>2007</year>; <volume>72</volume>: <fpage>45</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr6-1470320312438792">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Y</given-names></name>
<name><surname>Wongamorntham</surname><given-names>S</given-names></name>
<name><surname>Kasting</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms</article-title>. <source>Kidney Int</source> <year>2006</year>; <volume>69</volume>: <fpage>105</fpage>–<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr7-1470320312438792">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feldt</surname><given-names>S</given-names></name>
<name><surname>Batenburg</surname><given-names>WW</given-names></name>
<name><surname>Mazak</surname><given-names>I</given-names></name>
<etal/>
</person-group>. <article-title>Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide</article-title>. <source>Hypertension</source> <year>2008</year>; <volume>51</volume>: <fpage>682</fpage>–<lpage>688</lpage>.</citation>
</ref>
<ref id="bibr8-1470320312438792">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burcklé</surname><given-names>CA</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
<name><surname>Müller</surname><given-names>DN</given-names></name>
<etal/>
</person-group>. <article-title>Elevated blood pressure and heart rate in human renin receptor transgenic rats</article-title>. <source>Hypertension</source> <year>2006</year>; <volume>47</volume>: <fpage>552</fpage>–<lpage>556</lpage>.</citation>
</ref>
<ref id="bibr9-1470320312438792">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaneshiro</surname><given-names>Y</given-names></name>
<name><surname>Ichihara</surname><given-names>A</given-names></name>
<name><surname>Takemitsu</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats</article-title>. <source>Kidney Int</source> <year>2006</year>; <volume>70</volume>: <fpage>641</fpage>–<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr10-1470320312438792">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sakoda</surname><given-names>M</given-names></name>
<name><surname>Inomata</surname><given-names>K</given-names></name>
<name><surname>Mizuguchi</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Overexpression of (pro)renin receptor stimulates adrenal synthesis of aldosterone</article-title>. <source>Hypertension</source> <year>2008</year>; <volume>53</volume>: <fpage>e67</fpage>.</citation>
</ref>
<ref id="bibr11-1470320312438792">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Recarti</surname><given-names>C</given-names></name>
<name><surname>Seccia</surname><given-names>TM</given-names></name>
<name><surname>Lenzini</surname><given-names>L</given-names></name>
<name><surname>Caroccia</surname><given-names>B</given-names></name>
<name><surname>Pessina</surname><given-names>AC</given-names></name>
<name><surname>Rossi</surname><given-names>GP</given-names></name>
</person-group>. <article-title>High expression of the pro-renin receptor in aldosterone-producing adenoma causing human primary aldosteronism</article-title>. <source>J Hypertens</source> <year>2010</year>; <volume>28</volume>: <fpage>e215</fpage>.</citation>
</ref>
<ref id="bibr12-1470320312438792">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rincon Garriz</surname><given-names>JM</given-names></name>
<name><surname>Suarez</surname><given-names>C</given-names></name>
<name><surname>Capponi</surname><given-names>AM</given-names></name>
</person-group>. <article-title>c-Fos mediates angiotensin II-induced aldosterone production and protein synthesis in bovine adrenal glomerulosa cells</article-title>. <source>Endocrinology</source> <year>2009</year>; <volume>150</volume>: <fpage>1294</fpage>–<lpage>1302</lpage>.</citation>
</ref>
<ref id="bibr13-1470320312438792">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ansurudeen</surname><given-names>I</given-names></name>
<name><surname>Willenberg</surname><given-names>HS</given-names></name>
<name><surname>Kopprasch</surname><given-names>S</given-names></name>
<name><surname>Krug</surname><given-names>AW</given-names></name>
<name><surname>Ehrhart-Bornstein</surname><given-names>M</given-names></name>
<name><surname>Bornstein</surname><given-names>SR</given-names></name>
</person-group>. <article-title>Endothelial factors mediate aldosterone release via PKA-independent pathways</article-title>. <source>Mol Cell Endocrinol</source> <year>2009</year>; <volume>300</volume>: <fpage>66</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr14-1470320312438792">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saris</surname><given-names>JJ</given-names></name>
<name><surname>’t Hoen</surname><given-names>PAC</given-names></name>
<name><surname>Garrelds</surname><given-names>IM</given-names></name>
<etal/>
</person-group>. <article-title>Prorenin induces intracellular signalling in cardiomyocytes independently of angiotensin II</article-title>. <source>Hypertension</source> <year>2006</year>; <volume>48</volume>: <fpage>564</fpage>–<lpage>571</lpage>.</citation>
</ref>
<ref id="bibr15-1470320312438792">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chai</surname><given-names>W</given-names></name>
<name><surname>Hofland</surname><given-names>J</given-names></name>
<name><surname>Jansen</surname><given-names>PM</given-names></name>
<etal/>
</person-group>. <article-title>Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?</article-title> <source>J Hypertens</source> <year>2010</year>; <volume>28</volume>: <fpage>1044</fpage>–<lpage>1053</lpage>.</citation>
</ref>
<ref id="bibr16-1470320312438792">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gazdar</surname><given-names>AF</given-names></name>
<name><surname>Oie</surname><given-names>HK</given-names></name>
<name><surname>Shackleton</surname><given-names>CH</given-names></name>
<etal/>
</person-group>. <article-title>Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis</article-title>. <source>Cancer Res</source> <year>1990</year>; <volume>50</volume>: <fpage>5488</fpage>–<lpage>5496</lpage>.</citation>
</ref>
<ref id="bibr17-1470320312438792">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holland</surname><given-names>OB</given-names></name>
<name><surname>Mathis</surname><given-names>JM</given-names></name>
<name><surname>Bird</surname><given-names>IM</given-names></name>
<name><surname>Rainey</surname><given-names>WE</given-names></name>
</person-group>. <article-title>Angiotensin increases aldosterone synthase mRNA levels in human NCI-H295 cells</article-title>. <source>Mol Cell Endocrinol</source> <year>1993</year>; <volume>94</volume>: <fpage>R9</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr18-1470320312438792">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parmar</surname><given-names>J</given-names></name>
<name><surname>Key</surname><given-names>RE</given-names></name>
<name><surname>Rainey</surname><given-names>WE</given-names></name>
</person-group>. <article-title>Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line</article-title>. <source>J Clin Endocrinol Metab</source> <year>2008</year>; <volume>93</volume>: <fpage>4542</fpage>–<lpage>4546</lpage>.</citation>
</ref>
<ref id="bibr19-1470320312438792">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Batenburg</surname><given-names>WW</given-names></name>
<name><surname>Lu</surname><given-names>X</given-names></name>
<name><surname>Leijten</surname><given-names>F</given-names></name>
<name><surname>Maschke</surname><given-names>U</given-names></name>
<name><surname>Müller</surname><given-names>DN</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
</person-group>. <article-title>Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur?</article-title> <source>Hypertension</source> <year>2011</year>; <volume>58</volume>: <fpage>1111</fpage>–<lpage>1119</lpage>.</citation>
</ref>
<ref id="bibr20-1470320312438792">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Esch</surname><given-names>JHM</given-names></name>
<name><surname>Schuijt</surname><given-names>MP</given-names></name>
<name><surname>Sayed</surname><given-names>J</given-names></name>
<name><surname>Choudry</surname><given-names>Y</given-names></name>
<name><surname>Walther</surname><given-names>T</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
</person-group>. <article-title>AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation</article-title>. <source>Br J Pharmacol</source> <year>2006</year>; <volume>148</volume>: <fpage>452</fpage>–<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr21-1470320312438792">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moltzer</surname><given-names>E</given-names></name>
<name><surname>Verkuil</surname><given-names>AV</given-names></name>
<name><surname>van Veghel</surname><given-names>R</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
<name><surname>van Esch</surname><given-names>JHM</given-names></name>
</person-group>. <article-title>Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation</article-title>. <source>Hypertension</source> <year>2010</year>; <volume>55</volume>: <fpage>516</fpage>–<lpage>522</lpage>.</citation>
</ref>
<ref id="bibr22-1470320312438792">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krop</surname><given-names>M</given-names></name>
<name><surname>van Veghel</surname><given-names>R</given-names></name>
<name><surname>Garrelds</surname><given-names>IM</given-names></name>
<etal/>
</person-group>. <article-title>Cardiac renin levels are not influenced by the amount of resident mast cells</article-title>. <source>Hypertension</source> <year>2009</year>; <volume>54</volume>: <fpage>315</fpage>–<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr23-1470320312438792">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tom</surname><given-names>B</given-names></name>
<name><surname>Garrelds</surname><given-names>IM</given-names></name>
<name><surname>Scalbert</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>ACE- versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?</article-title> <source>Arterioscler Thromb Vasc Biol</source> <year>2003</year>; <volume>23</volume>: <fpage>251</fpage>–<lpage>256</lpage>.</citation>
</ref>
<ref id="bibr24-1470320312438792">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saris</surname><given-names>JJ</given-names></name>
<name><surname>Derkx</surname><given-names>FHM</given-names></name>
<name><surname>de Bruin</surname><given-names>RJA</given-names></name>
<etal/>
</person-group>. <article-title>High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin</article-title>. <source>Am J Physiol</source> <year>2001</year>; <volume>280</volume>: <fpage>H1706</fpage>–<lpage>H1715</lpage>.</citation>
</ref>
<ref id="bibr25-1470320312438792">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hofland</surname><given-names>J</given-names></name>
<name><surname>Timmerman</surname><given-names>MA</given-names></name>
<name><surname>de Herder</surname><given-names>WW</given-names></name>
<name><surname>van Schaik</surname><given-names>RHN</given-names></name>
<name><surname>de Krijger</surname><given-names>RR</given-names></name>
<name><surname>de Jong</surname><given-names>FH</given-names></name>
</person-group>. <article-title>Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms</article-title>. <source>Clin Endocrinol (Oxf)</source> <year>2006</year>; <volume>65</volume>: <fpage>792</fpage>–<lpage>799</lpage>.</citation>
</ref>
<ref id="bibr26-1470320312438792">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krop</surname><given-names>M</given-names></name>
<name><surname>Garrelds</surname><given-names>IM</given-names></name>
<name><surname>de Bruin</surname><given-names>RJA</given-names></name>
<etal/>
</person-group>. <article-title>Aliskiren accumulates in renin secretory granules and binds plasma prorenin</article-title>. <source>Hypertension</source> <year>2008</year>; <volume>52</volume>: <fpage>1076</fpage>–<lpage>1083</lpage>.</citation>
</ref>
<ref id="bibr27-1470320312438792">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schuijt</surname><given-names>MP</given-names></name>
<name><surname>de Vries</surname><given-names>R</given-names></name>
<name><surname>Saxena</surname><given-names>PR</given-names></name>
<name><surname>Schalekamp</surname><given-names>MADH</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
</person-group>. <article-title>Vasoconstriction is determined by interstitial rather than circulating angiotensin II</article-title>. <source>Br J Pharmacol</source> <year>2002</year>; <volume>135</volume>: <fpage>275</fpage>–<lpage>283</lpage>.</citation>
</ref>
<ref id="bibr28-1470320312438792">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Advani</surname><given-names>A</given-names></name>
<name><surname>Kelly</surname><given-names>DJ</given-names></name>
<name><surname>Cox</surname><given-names>AJ</given-names></name>
<etal/>
</person-group>. <article-title>The (pro)renin receptor: site-specific and functional linkage to the vacuolar H<sup>+</sup>-ATPase in the kidney</article-title>. <source>Hypertension</source> <year>2009</year>; <volume>54</volume>: <fpage>261</fpage>–<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr29-1470320312438792">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
<name><surname>Derkx</surname><given-names>FHM</given-names></name>
<name><surname>Schalekamp</surname><given-names>MADH</given-names></name>
<name><surname>Hense</surname><given-names>HW</given-names></name>
<name><surname>Riegger</surname><given-names>GAJ</given-names></name>
<name><surname>Schunkert</surname><given-names>H</given-names></name>
</person-group>. <article-title>Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans</article-title>. <source>J Hypertens</source> <year>1998</year>; <volume>16</volume>: <fpage>853</fpage>–<lpage>862</lpage>.</citation>
</ref>
<ref id="bibr30-1470320312438792">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klotz</surname><given-names>S</given-names></name>
<name><surname>Burkhoff</surname><given-names>D</given-names></name>
<name><surname>Garrelds</surname><given-names>IM</given-names></name>
<name><surname>Boomsma</surname><given-names>F</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
</person-group>. <article-title>The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?</article-title> <source>Eur Heart J</source> <year>2009</year>; <volume>30</volume>: <fpage>805</fpage>–<lpage>812</lpage>.</citation>
</ref>
<ref id="bibr31-1470320312438792">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fisher</surname><given-names>NDL</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
<name><surname>Nussberger</surname><given-names>J</given-names></name>
<name><surname>Dole</surname><given-names>WP</given-names></name>
<name><surname>Hollenberg</surname><given-names>NK</given-names></name>
</person-group>. <article-title>Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans</article-title>. <source>Circulation</source> <year>2008</year>; <volume>117</volume>: <fpage>3199</fpage>–<lpage>3205</lpage>.</citation>
</ref>
<ref id="bibr32-1470320312438792">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hilbers</surname><given-names>U</given-names></name>
<name><surname>Peters</surname><given-names>J</given-names></name>
<name><surname>Bornstein</surname><given-names>SR</given-names></name>
<etal/>
</person-group>. <article-title>Local renin–angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells</article-title>. <source>Hypertension</source> <year>1999</year>; <volume>33</volume>: <fpage>1025</fpage>–<lpage>1030</lpage>.</citation>
</ref>
<ref id="bibr33-1470320312438792">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clausmeyer</surname><given-names>S</given-names></name>
<name><surname>Sturzebecher</surname><given-names>R</given-names></name>
<name><surname>Peters</surname><given-names>J</given-names></name>
</person-group>. <article-title>An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondria</article-title>. <source>Circ Res</source> <year>1999</year>; <volume>84</volume>: <fpage>337</fpage>–<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr34-1470320312438792">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>J</given-names></name>
<name><surname>Wanka</surname><given-names>H</given-names></name>
<name><surname>Peters</surname><given-names>B</given-names></name>
<name><surname>Hoffmann</surname><given-names>S</given-names></name>
</person-group>. <article-title>A renin transcript lacking exon 1 encodes for a non-secretory intracellular renin that increases aldosterone production in transgenic rats</article-title>. <source>J Cell Mol Med</source> <year>2008</year>; <volume>12</volume>: <fpage>1229</fpage>–<lpage>1237</lpage>.</citation>
</ref>
<ref id="bibr35-1470320312438792">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van den Eijnden</surname><given-names>MMED</given-names></name>
<name><surname>Saris</surname><given-names>JJ</given-names></name>
<name><surname>de Bruin</surname><given-names>RJA</given-names></name>
<etal/>
</person-group>. <article-title>Prorenin accumulation and activation in human endothelial cells. Importance of mannose 6-phosphate receptors</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <year>2001</year>; <volume>21</volume>: <fpage>911</fpage>–<lpage>916</lpage>.</citation>
</ref>
<ref id="bibr36-1470320312438792">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saris</surname><given-names>JJ</given-names></name>
<name><surname>Derkx</surname><given-names>FHM</given-names></name>
<name><surname>Lamers</surname><given-names>JMJ</given-names></name>
<name><surname>Saxena</surname><given-names>PR</given-names></name>
<name><surname>Schalekamp</surname><given-names>MADH</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
</person-group>. <article-title>Cardiomyocytes bind and activate native human prorenin: role of soluble mannose 6-phosphate receptors</article-title>. <source>Hypertension</source> <year>2001</year>; <volume>37</volume>: <fpage>710</fpage>–<lpage>715</lpage>.</citation>
</ref>
<ref id="bibr37-1470320312438792">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kinouchi</surname><given-names>K</given-names></name>
<name><surname>Ichihara</surname><given-names>A</given-names></name>
<name><surname>Sano</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes</article-title>. <source>Circ Res</source> <year>2010</year>; <volume>107</volume>: <fpage>30</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr38-1470320312438792">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaneshiro</surname><given-names>Y</given-names></name>
<name><surname>Ichihara</surname><given-names>A</given-names></name>
<name><surname>Sakoda</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats</article-title>. <source>J Am Soc Nephrol</source> <year>2007</year>; <volume>18</volume>: <fpage>1789</fpage>–<lpage>1795</lpage>.</citation>
</ref>
<ref id="bibr39-1470320312438792">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bomback</surname><given-names>AS</given-names></name>
<name><surname>Klemmer</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>The incidence and implications of aldosterone breakthrough</article-title>. <source>Nat Clin Pract Nephrol</source> <year>2007</year>; <volume>3</volume>: <fpage>486</fpage>–<lpage>492</lpage>.</citation>
</ref>
<ref id="bibr40-1470320312438792">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Staessen</surname><given-names>J</given-names></name>
<name><surname>Lijnen</surname><given-names>P</given-names></name>
<name><surname>Fagard</surname><given-names>R</given-names></name>
<name><surname>Verschueren</surname><given-names>LJ</given-names></name>
<name><surname>Amery</surname><given-names>A</given-names></name>
</person-group>. <article-title>Rise in plasma concentration of aldosterone during long-term angiotensin II suppression</article-title>. <source>J Endocrinol</source> <year>1981</year>; <volume>91</volume>: <fpage>457</fpage>-<lpage>465</lpage>.</citation>
</ref>
<ref id="bibr41-1470320312438792">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Kats</surname><given-names>JP</given-names></name>
<name><surname>Chai</surname><given-names>W</given-names></name>
<name><surname>Duncker</surname><given-names>DJ</given-names></name>
<name><surname>Schalekamp</surname><given-names>MADH</given-names></name>
<name><surname>Danser</surname><given-names>AHJ</given-names></name>
</person-group>. <article-title>Adrenal angiotensin. Origin and site of generation</article-title>. <source>Am J Hypertens</source> <year>2005</year>; <volume>18</volume>: <fpage>1045</fpage>–<lpage>1051</lpage>.</citation>
</ref>
<ref id="bibr42-1470320312438792">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Kats</surname><given-names>JP</given-names></name>
<name><surname>Duncker</surname><given-names>DJ</given-names></name>
<name><surname>Haitsma</surname><given-names>DB</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II</article-title>. <source>Circulation</source> <year>2000</year>; <volume>102</volume>: <fpage>1556</fpage>–<lpage>1563</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>